tiprankstipranks
Clinigen Group PLC (CLIGF)
OTHER OTC:CLIGF
US Market

Clinigen (CLIGF) Financial Statements

0 Followers

Clinigen Financial Overview

Clinigen's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Clinigen is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Jun 21Dec 20Jun 20Dec 19
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 117.50M£ 82.90M£ 62.90M£ 143.10M£ 39.80M
Total Assets£ 1.05B£ 1.07B£ 1.02B£ 1.14B£ 1.05B
Total Debt£ 413.10M£ 418.70M£ 414.40M£ 455.00M£ 362.10M
Net Debt£ 295.60M£ 335.80M£ 351.50M£ 311.90M£ 322.30M
Total Liabilities£ 593.50M£ 618.60M£ 583.80M£ 696.40M£ 605.60M
Stockholders Equity£ 455.10M£ 447.00M£ 437.90M£ 445.60M£ 440.80M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Clinigen Earnings and Revenue History

Clinigen Debt to Assets

Clinigen Cash Flow

Clinigen Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis